as on January 28, 2026 at 2:29 am IST
Day's Low
Day's High
1.90%
Downside
3.33%
Upside
52 Week's Low
52 Week's High
56.66%
Downside
116.06%
Upside
Check Editas Medicine Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$210.9M
EPS (TTM)
-1.9563
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.58
Industry PE ratio
-1.8136016949152542
PEG Ratio
0EBITDA
-112.0M
Revenue (TTM)
46.4M
Profit Margin
0.00%
Return On Equity TTM
-211.37%
Track how Editas Medicine Inc. P/E has moved over time to understand its valuation trends.
Editas Medicine Inc. in the last 5 years
Lowest (-26.25x)
March 31, 2021
Industry (-1.81x)
January 27, 2026
Today (-1.58x)
January 27, 2026
Highest (-0.48x)
March 31, 2025
Today’s Price to Earnings Ratio: -1.58x
Compare market cap, revenue, PE, and other key metrics of Editas Medicine Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $210.9M | -96.6% | -1.58 | 0.00% | |
| BUY | $47.3B | 132.54% | 1234.41 | 1.36% | |
| BUY | $120.1B | 111.69% | 33.01 | 31.35% | |
| NA | $37.5B | NA | 665.33 | 1.38% | |
| BUY | $79.9B | 47.93% | 18.05 | 32.13% |
The Editas Medicine Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Editas Medicine Inc. investment value today
Current value as on today
₹1,55,129
Returns
₹55,129
(+55.13%)
Returns from Editas Medicine Inc. Stock
₹48,936 (+48.94%)
Dollar Returns*
₹6,193 (+6.19%)
Based on 24 analysts
54.17%
Buy
41.67%
Hold
4.17%
Sell
Based on 24 analysts, 54.17% of analysts recommend a 'BUY' rating for Editas Medicine Inc.. Average target price of $5.12
Get share price movements and forecasts by analysts on Editas Medicine Inc..
What analysts predicted
58.98%UPSIDE
Target Price
$5.12
Current Price
$2.1
Analyzed by
24 Analysts
Target
$5.12
Editas Medicine Inc. target price $5.12, a slight upside of 58.98% compared to current price of $2.1. According to 24 analysts rating.
Search interest for Editas Medicine Inc. Stock has increased by 17% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:17% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -76.08M → -25.11M (in $), with an average increase of 77.4% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 3.57M → 7.54M (in $), with an average increase of 52.6% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 50.0% return, outperforming this stock by 3.9%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 30.0% return, outperforming this stock by 108.5%
Price Dip
![]()
In the last 3 months, EDIT stock has moved down by -36.6%
| Organisation | Editas Medicine Inc. |
| Headquarters | 11 Hurley Street, Cambridge, MA, United States, 02141 |
| Industry | Health Technology |
| CEO | Dr. Gilmore O'Neill M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Gilmore O'Neill M.D. | President, CEO & Director |
Dr. Feng Zhang Ph.D. | Co-Founder & Scientific Advisory Board Member |
Ms. Amy Parison | Senior VP & CFO |
Mr. Gregory Whitehead | Executive VP and Chief Technical & Quality Officer |
Cristi Barnett | Senior VP of Corporate Communications & Investor Relations |
Mr. Frank Panaccio | Senior VP & Chief Business Officer |
Dr. George McDonald Church Ph.D. | Co-Founder & Scientific Advisory Board Member |
Dr. Linda C. Burkly Ph.D. | Executive VP & Chief Scientific Officer |
Mr. Damien Grierson J.D. | Senior VP, General Counsel & Corporate Secretary |
Ms. Brieana Buckley | Senior Vice President of Development and Program Leadership |
Editas Medicine Inc. share price today is $2.1 as on at the close of the market. Editas Medicine Inc. share today touched a day high of $2.17 and a low of $2.06.
Editas Medicine Inc. share touched a 52 week high of $4.54 on and a 52 week low of $0.91 on . Editas Medicine Inc. stock price today i.e. is closed at $2.1,which is 53.72% down from its 52 week high and 130.74% up from its 52 week low.
Editas Medicine Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Editas Medicine Inc. (EDIT) shares with as little as ₹91.708 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.08 in Editas Medicine Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Editas Medicine Inc. share’s latest price of $2.1 as on January 28, 2026 at 2:29 am IST, you will get 4.7619 shares of Editas Medicine Inc.. Learn more about
fractional shares .
Editas Medicine Inc. stock has given -96.6% share price returns and 25.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?